Breast cancer angiogenesis: therapy target and prognostic factor.
Harris
A L
AL
ICRF Molecular Oncology Laboratories, John Radcliffe Hospital, Headington, Oxford, U.K.
Fox
S
S
Leek
R
R
Zhang
H
H
Scott
P
P
Bicknell
R
R
Gatter
K
K
D043925:Angiogenesis Inducing Agents / Q000037:antagonists & inhibitors; D001943:Breast Neoplasms / Q000098:blood supply* / Q000628:therapy; D005260:Female; D006801:Humans; D009389:Neovascularization, Pathologic / Q000209:etiology / Q000628:therapy; D011379:Prognosis
D043925:Angiogenesis Inducing Agents